{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T16:21:04Z","timestamp":1773332464111,"version":"3.50.1"},"reference-count":107,"publisher":"The Endocrine Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,6,1]]},"DOI":"10.1210\/en.2016-1707","type":"journal-article","created":{"date-parts":[[2017,5,4]],"date-time":"2017-05-04T19:07:03Z","timestamp":1493924823000},"page":"1859-1874","source":"Crossref","is-referenced-by-count":25,"title":["Role and Regulation of MicroRNAs in Aldosterone-Mediated Cardiac Injury and Dysfunction in Male Rats"],"prefix":"10.1210","volume":"158","author":[{"given":"Jana P.","family":"Ball","sequence":"first","affiliation":[{"name":"Department of Biochemistry, University of Mississippi Medical Center, Jackson, Mississippi 39216"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Syed","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, University of Mississippi Medical Center, Jackson, Mississippi 39216"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo O.","family":"Mara\u00f1on","sequence":"additional","affiliation":[{"name":"Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, Mississippi 39216"},{"name":"Cardio-Renal Research Center, University of Mississippi Medical Center, Jackson, Mississippi 39216"},{"name":"Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi 39216"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael E.","family":"Hall","sequence":"additional","affiliation":[{"name":"Cardio-Renal Research Center, University of Mississippi Medical Center, Jackson, Mississippi 39216"},{"name":"Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi 39216"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roshan","family":"KC","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, University of Mississippi Medical Center, Jackson, Mississippi 39216"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane F.","family":"Reckelhoff","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, University of Mississippi Medical Center, Jackson, Mississippi 39216"},{"name":"Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, Mississippi 39216"},{"name":"Cardio-Renal Research Center, University of Mississippi Medical Center, Jackson, Mississippi 39216"},{"name":"Women\u2019s Health Research Center, University of Mississippi Medical Center, Jackson, Mississippi 39216"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Licy L.","family":"Yanes Cardozo","sequence":"additional","affiliation":[{"name":"Cardio-Renal Research Center, University of Mississippi Medical Center, Jackson, Mississippi 39216"},{"name":"Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi 39216"},{"name":"Women\u2019s Health Research Center, University of Mississippi Medical Center, Jackson, Mississippi 39216"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damian G.","family":"Romero","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, University of Mississippi Medical Center, Jackson, Mississippi 39216"},{"name":"Cardio-Renal Research Center, University of Mississippi Medical Center, Jackson, Mississippi 39216"},{"name":"Women\u2019s Health Research Center, University of Mississippi Medical Center, Jackson, Mississippi 39216"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2017,3,20]]},"reference":[{"issue":"6","key":"2019041123325105900_B1","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1161\/01.RES.67.6.1355","article-title":"Remodeling of the rat right and left ventricles in experimental hypertension","volume":"67","author":"Brilla","year":"1990","journal-title":"Circ Res"},{"issue":"6","key":"2019041123325105900_B2","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1172\/JCI117269","article-title":"Mineralocorticoids, hypertension, and cardiac fibrosis","volume":"93","author":"Young","year":"1994","journal-title":"J Clin Invest"},{"issue":"5","key":"2019041123325105900_B3","doi-asserted-by":"crossref","first-page":"H1802","DOI":"10.1152\/ajpheart.01096.2001","article-title":"Aldosterone induces a vascular inflammatory phenotype in the rat heart","volume":"283","author":"Rocha","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"10","key":"2019041123325105900_B4","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1210\/endo.141.10.7711","article-title":"Aldosterone: a mediator of myocardial necrosis and renal arteriopathy","volume":"141","author":"Rocha","year":"2000","journal-title":"Endocrinology"},{"issue":"9","key":"2019041123325105900_B5","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1042\/CS20060275","article-title":"Mineralocorticoid receptor activation and cardiac fibrosis","volume":"112","author":"Young","year":"2007","journal-title":"Clin Sci (Lond)"},{"issue":"6","key":"2019041123325105900_B6","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1042\/CS20070123","article-title":"Aldosterone and end-organ damage","volume":"113","author":"Marney","year":"2007","journal-title":"Clin Sci (Lond)"},{"issue":"23","key":"2019041123325105900_B7","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1056\/NEJMra000050","article-title":"Aldosterone in congestive heart failure","volume":"345","author":"Weber","year":"2001","journal-title":"N Engl J Med"},{"issue":"3","key":"2019041123325105900_B8","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1210\/jc.2003-031337","article-title":"Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents","volume":"89","author":"Mulatero","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041123325105900_B9","doi-asserted-by":"crossref","DOI":"10.1038\/ncpneph0151","article-title":"Primary aldosteronism: diagnostic and treatment strategies","volume":"2","author":"Mattsson","year":"2006","journal-title":"Nat Clin Pract Nephrol."},{"issue":"3","key":"2019041123325105900_B10","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1161\/HYPERTENSIONAHA.106.086116","article-title":"Is there an unrecognized epidemic of primary aldosteronism? Pro","volume":"50","author":"Calhoun","year":"2007","journal-title":"Hypertension"},{"issue":"6","key":"2019041123325105900_B11","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1210\/en.2003-0279","article-title":"Minireview: primary aldosteronism--changing concepts in diagnosis and treatment","volume":"144","author":"Young","year":"2003","journal-title":"Endocrinology"},{"issue":"10","key":"2019041123325105900_B12","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1210\/jc.2009-1399","article-title":"Update in primary aldosteronism","volume":"94","author":"Stowasser","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2019041123325105900_B13","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","article-title":"Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline","volume":"93","author":"Funder","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2019041123325105900_B14","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1210\/jc.2013-2805","article-title":"Long-term cardio- and cerebrovascular events in patients with primary aldosteronism","volume":"98","author":"Mulatero","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019041123325105900_B15","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1161\/HYPERTENSIONAHA.113.01060","article-title":"Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study","volume":"62","author":"Savard","year":"2013","journal-title":"Hypertension"},{"issue":"8","key":"2019041123325105900_B16","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"2019041123325105900_B17","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/eurheartj\/ehq019","article-title":"Plasma aldosterone levels are associated with increased cardiovascular mortality: the Ludwigshafen Risk and Cardiovascular Health (LURIC) study","volume":"31","author":"Tomaschitz","year":"2010","journal-title":"Eur Heart J"},{"issue":"2","key":"2019041123325105900_B18","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"issue":"7330","key":"2019041123325105900_B19","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/nature09783","article-title":"Pervasive roles of microRNAs in cardiovascular biology","volume":"469","author":"Small","year":"2011","journal-title":"Nature"},{"issue":"3","key":"2019041123325105900_B20","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/ncb0309-228","article-title":"Many roads to maturity: microRNA biogenesis pathways and their regulation","volume":"11","author":"Winter","year":"2009","journal-title":"Nat Cell Biol"},{"issue":"21","key":"2019041123325105900_B21","doi-asserted-by":"crossref","first-page":"4645","DOI":"10.1242\/dev.02070","article-title":"microPrimer: the biogenesis and function of microRNA","volume":"132","author":"Du","year":"2005","journal-title":"Development"},{"issue":"8","key":"2019041123325105900_B22","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nrm3611","article-title":"Diversifying microRNA sequence and function","volume":"14","author":"Ameres","year":"2013","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2019041123325105900_B23","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1146\/annurev-biochem-060308-103103","article-title":"Regulation of mRNA translation and stability by microRNAs","volume":"79","author":"Fabian","year":"2010","journal-title":"Annu Rev Biochem"},{"key":"2019041123325105900_B24","doi-asserted-by":"crossref","DOI":"10.1038\/nrg2455","article-title":"Biological principles of microRNA-mediated regulation: shared themes amid diversity","volume":"9","author":"Flynt","year":"2008","journal-title":"Nat Rev Genet"},{"key":"2019041123325105900_B25","doi-asserted-by":"crossref","DOI":"10.1038\/nrg2936","article-title":"Gene silencing by microRNAs: contributions of translational repression and mRNA decay","volume":"12","author":"Huntzinger","year":"2011","journal-title":"Nat Rev Genet"},{"issue":"6","key":"2019041123325105900_B26","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/nsmb.2296","article-title":"The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC","volume":"19","author":"Fabian","year":"2012","journal-title":"Nat Struct Mol Biol"},{"key":"2019041123325105900_B27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev.cellbio.23.090506.123406","article-title":"microRNA functions","volume":"23","author":"Bushati","year":"2007","journal-title":"Annu Rev Cell Dev Biol"},{"key":"2019041123325105900_B28","doi-asserted-by":"crossref","DOI":"10.1038\/nrg3471","article-title":"Adult-specific functions of animal microRNAs","volume":"14","author":"Sun","year":"2013","journal-title":"Nat Rev Genet"},{"issue":"3","key":"2019041123325105900_B29","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1152\/physrev.00006.2010","article-title":"MicroRNAs in development and disease","volume":"91","author":"Sayed","year":"2011","journal-title":"Physiol Rev"},{"issue":"8","key":"2019041123325105900_B30","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1161\/CIRCULATIONAHA.109.889048","article-title":"MicroRNAs add a new dimension to cardiovascular disease","volume":"121","author":"Small","year":"2010","journal-title":"Circulation"},{"issue":"3","key":"2019041123325105900_B31","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1152\/physiolgenomics.90254.2008","article-title":"MicroRNA and cardiac pathologies","volume":"34","author":"Latronico","year":"2008","journal-title":"Physiol Genomics"},{"issue":"5","key":"2019041123325105900_B32","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/FJC.0b013e3181ee81df","article-title":"Regulation of myocardial fibrosis by MicroRNAs","volume":"56","author":"Bauersachs","year":"2010","journal-title":"J Cardiovasc Pharmacol"},{"issue":"3","key":"2019041123325105900_B33","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/HCO.0b013e328345983d","article-title":"MicroRNAs in the cardiovascular system","volume":"26","author":"Han","year":"2011","journal-title":"Curr Opin Cardiol"},{"issue":"4","key":"2019041123325105900_B34","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1161\/HYPERTENSIONAHA.111.00654","article-title":"MicroRNAs involved in the regulation of postischemic cardiac fibrosis","volume":"61","author":"Dai","year":"2013","journal-title":"Hypertension"},{"issue":"4","key":"2019041123325105900_B35","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/cvr\/cvr344","article-title":"Non-cardiomyocyte microRNAs in heart failure","volume":"93","author":"Tijsen","year":"2012","journal-title":"Cardiovasc Res"},{"issue":"21","key":"2019041123325105900_B36","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/j.jacc.2014.01.050","article-title":"microRNAs in cardiovascular diseases: current knowledge and the road ahead","volume":"63","author":"Condorelli","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"2019041123325105900_B37","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.2353\/ajpath.2007.061170","article-title":"MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy?","volume":"170","author":"Cheng","year":"2007","journal-title":"Am J Pathol"},{"issue":"6","key":"2019041123325105900_B38","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.yjmcc.2007.04.004","article-title":"Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy","volume":"42","author":"Tatsuguchi","year":"2007","journal-title":"J Mol Cell Cardiol"},{"issue":"7224","key":"2019041123325105900_B39","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/nature07511","article-title":"MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts","volume":"456","author":"Thum","year":"2008","journal-title":"Nature"},{"issue":"3","key":"2019041123325105900_B40","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1161\/CIRCULATIONAHA.107.687947","article-title":"MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure","volume":"116","author":"Thum","year":"2007","journal-title":"Circulation"},{"issue":"9","key":"2019041123325105900_B41","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1161\/CIRCULATIONAHA.108.813576","article-title":"Reciprocal regulation of myocardial microRNAs and messenger RNA in human cardiomyopathy and reversal of the microRNA signature by biomechanical support","volume":"119","author":"Matkovich","year":"2009","journal-title":"Circulation"},{"issue":"9","key":"2019041123325105900_B42","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1161\/CIRCULATIONAHA.113.003863","article-title":"Deep RNA sequencing reveals dynamic regulation of myocardial noncoding RNAs in failing human heart and remodeling with mechanical circulatory support","volume":"129","author":"Yang","year":"2014","journal-title":"Circulation"},{"issue":"12","key":"2019041123325105900_B43","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.biocel.2012.08.019","article-title":"A novel reciprocal loop between microRNA-21 and TGF\u03b2RIII is involved in cardiac fibrosis","volume":"44","author":"Liang","year":"2012","journal-title":"Int J Biochem Cell Biol"},{"issue":"5","key":"2019041123325105900_B44","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s00395-012-0278-0","article-title":"Role of miR-21 in the pathogenesis of atrial fibrosis","volume":"107","author":"Adam","year":"2012","journal-title":"Basic Res Cardiol"},{"issue":"5","key":"2019041123325105900_B45","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1161\/CIRCEP.112.973214","article-title":"Role for MicroRNA-21 in atrial profibrillatory fibrotic remodeling associated with experimental postinfarction heart failure","volume":"5","author":"Cardin","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"5","key":"2019041123325105900_B46","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1172\/JCI70577","article-title":"Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy","volume":"124","author":"Bang","year":"2014","journal-title":"J Clin Invest"},{"issue":"32","key":"2019041123325105900_B47","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1093\/eurheartj\/ehv109","article-title":"Osteopontin is indispensible for AP1-mediated angiotensin II-related miR-21 transcription during cardiac fibrosis","volume":"36","author":"Lorenzen","year":"2015","journal-title":"Eur Heart J"},{"issue":"7","key":"2019041123325105900_B48","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1161\/CIRCEP.115.003396","article-title":"Signal transducer and activator of transcription 3\/MicroRNA-21 feedback loop contributes to atrial fibrillation by promoting atrial fibrosis in a rat sterile pericarditis model","volume":"9","author":"Huang","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"8","key":"2019041123325105900_B49","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1091\/mbc.e08-02-0159","article-title":"MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths","volume":"19","author":"Sayed","year":"2008","journal-title":"Mol Biol Cell"},{"issue":"1","key":"2019041123325105900_B50","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.yjmcc.2009.01.008","article-title":"MicroRNA-21 protects against the H(2)O(2)-induced injury on cardiac myocytes via its target gene PDCD4","volume":"47","author":"Cheng","year":"2009","journal-title":"J Mol Cell Cardiol"},{"issue":"43","key":"2019041123325105900_B51","doi-asserted-by":"crossref","first-page":"29514","DOI":"10.1074\/jbc.M109.027896","article-title":"MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction","volume":"284","author":"Dong","year":"2009","journal-title":"J Biol Chem"},{"issue":"30","key":"2019041123325105900_B52","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.1016\/j.febslet.2008.11.014","article-title":"Endogenous microRNAs induced by heat-shock reduce myocardial infarction following ischemia-reperfusion in mice","volume":"582","author":"Yin","year":"2008","journal-title":"FEBS Lett"},{"issue":"26","key":"2019041123325105900_B53","doi-asserted-by":"crossref","first-page":"20281","DOI":"10.1074\/jbc.M110.109207","article-title":"MicroRNA-21 is a downstream effector of AKT that mediates its antiapoptotic effects via suppression of Fas ligand","volume":"285","author":"Sayed","year":"2010","journal-title":"J Biol Chem"},{"issue":"11","key":"2019041123325105900_B54","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1172\/JCI43604","article-title":"Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice","volume":"120","author":"Patrick","year":"2010","journal-title":"J Clin Invest"},{"issue":"3","key":"2019041123325105900_B55","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/cvr\/cvq082","article-title":"Ischaemic preconditioning-regulated miR-21 protects heart against ischaemia\/reperfusion injury via anti-apoptosis through its target PDCD4","volume":"87","author":"Cheng","year":"2010","journal-title":"Cardiovasc Res"},{"issue":"6","key":"2019041123325105900_B56","doi-asserted-by":"crossref","first-page":"413","DOI":"10.7150\/ijms.4514","article-title":"MicroRNA 21 inhibits left ventricular remodeling in the early phase of rat model with ischemia-reperfusion injury by suppressing cell apoptosis","volume":"9","author":"Qin","year":"2012","journal-title":"Int J Med Sci"},{"issue":"12","key":"2019041123325105900_B57","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1161\/CIRCULATIONAHA.111.060269","article-title":"MicroRNA-21 integrates pathogenic signaling to control pulmonary hypertension: results of a network bioinformatics approach","volume":"125","author":"Parikh","year":"2012","journal-title":"Circulation"},{"issue":"3","key":"2019041123325105900_B58","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1161\/CIRCGENETICS.113.000381","article-title":"Induction of microRNA-21 with exogenous hydrogen sulfide attenuates myocardial ischemic and inflammatory injury in mice","volume":"7","author":"Toldo","year":"2014","journal-title":"Circ Cardiovasc Genet"},{"issue":"6","key":"2019041123325105900_B59","doi-asserted-by":"crossref","first-page":"e2277","DOI":"10.1038\/cddis.2016.181","article-title":"Cardiac progenitor cell-derived exosomes prevent cardiomyocytes apoptosis through exosomal miR-21 by targeting PDCD4","volume":"7","author":"Xiao","year":"2016","journal-title":"Cell Death Dis"},{"issue":"4","key":"2019041123325105900_B60","doi-asserted-by":"crossref","first-page":"F771","DOI":"10.1152\/ajprenal.90389.2008","article-title":"Testosterone-dependent hypertension and upregulation of intrarenal angiotensinogen in Dahl salt-sensitive rats","volume":"296","author":"Yanes","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"issue":"3","key":"2019041123325105900_B61","doi-asserted-by":"crossref","first-page":"E316","DOI":"10.1152\/ajpendo.00005.2014","article-title":"Rescue of cardiac leptin receptors in db\/db mice prevents myocardial triglyceride accumulation","volume":"307","author":"Hall","year":"2014","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"12","key":"2019041123325105900_B62","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","article-title":"Recommendations for chamber quantification: a report from the American Society of Echocardiography\u2019s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology","volume":"18","author":"Lang","year":"2005","journal-title":"J Am Soc Echocardiogr"},{"issue":"7068","key":"2019041123325105900_B63","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nature04303","article-title":"Silencing of microRNAs in vivo with \u2018antagomirs\u2019","volume":"438","author":"Kr\u00fctzfeldt","year":"2005","journal-title":"Nature"},{"issue":"9","key":"2019041123325105900_B64","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1093\/nar\/gkm024","article-title":"Specificity, duplex degradation and subcellular localization of antagomirs","volume":"35","author":"Kr\u00fctzfeldt","year":"2007","journal-title":"Nucleic Acids Res"},{"issue":"Database issue","key":"2019041123325105900_B65","doi-asserted-by":"crossref","first-page":"D68","DOI":"10.1093\/nar\/gkt1181","article-title":"miRBase: annotating high confidence microRNAs using deep sequencing data","volume":"42","author":"Kozomara","year":"2014","journal-title":"Nucleic Acids Res"},{"issue":"20","key":"2019041123325105900_B66","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1093\/bioinformatics\/btm412","article-title":"A comparison of background correction methods for two-colour microarrays","volume":"23","author":"Ritchie","year":"2007","journal-title":"Bioinformatics"},{"issue":"1","key":"2019041123325105900_B67","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1152\/physiolgenomics.00101.2005","article-title":"Pathway analysis of coronary atherosclerosis","volume":"23","author":"King","year":"2005","journal-title":"Physiol Genomics"},{"issue":"4","key":"2019041123325105900_B68","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"6","key":"2019041123325105900_B69","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat Protoc"},{"issue":"2","key":"2019041123325105900_B70","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.neuroscience.2008.07.047","article-title":"Housekeeping genes revisited: different expressions depending on gender, brain area and stressor","volume":"156","author":"Derks","year":"2008","journal-title":"Neuroscience"},{"issue":"4","key":"2019041123325105900_B71","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.bbrc.2003.11.177","article-title":"Guideline to reference gene selection for quantitative real-time PCR","volume":"313","author":"Radoni\u0107","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"2019041123325105900_B72","first-page":"365","article-title":"Primer3 on the WWW for general users and for biologist programmers","volume":"132","author":"Rozen","year":"2000","journal-title":"Methods Mol Biol"},{"issue":"6","key":"2019041123325105900_B73","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1210\/en.2006-1509","article-title":"Disabled-2 is expressed in adrenal zona glomerulosa and is involved in aldosterone secretion","volume":"148","author":"Romero","year":"2007","journal-title":"Endocrinology"},{"issue":"2","key":"2019041123325105900_B74","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/nprot.2007.528","article-title":"MicroRNA detection by northern blotting using locked nucleic acid probes","volume":"3","author":"V\u00e1rallyay","year":"2008","journal-title":"Nat Protoc"},{"issue":"3","key":"2019041123325105900_B75","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0022-2828(86)80410-2","article-title":"A biochemical method for the quantitation of myocardial scarring after experimental coronary artery occlusion","volume":"18","author":"Chiariello","year":"1986","journal-title":"J Mol Cell Cardiol"},{"issue":"11","key":"2019041123325105900_B76","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients","volume":"48","author":"Rossi","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"2019041123325105900_B77","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2019041123325105900_B78","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1161\/CIRCRESAHA.115.305242","article-title":"Function and therapeutic potential of noncoding RNAs in cardiac fibrosis","volume":"118","author":"Creemers","year":"2016","journal-title":"Circ Res"},{"issue":"3","key":"2019041123325105900_B79","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nrcardio.2014.207","article-title":"MicroRNAs in myocardial infarction","volume":"12","author":"Boon","year":"2015","journal-title":"Nat Rev Cardiol"},{"issue":"2","key":"2019041123325105900_B80","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/nrcardio.2014.178","article-title":"MicroRNAs and atrial fibrillation: mechanisms and translational potential","volume":"12","author":"Luo","year":"2015","journal-title":"Nat Rev Cardiol"},{"issue":"29","key":"2019041123325105900_B81","doi-asserted-by":"crossref","first-page":"12103","DOI":"10.1073\/pnas.0811371106","article-title":"miR-23a functions downstream of NFATc3 to regulate cardiac hypertrophy","volume":"106","author":"Lin","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"issue":"16","key":"2019041123325105900_B82","doi-asserted-by":"crossref","first-page":"11903","DOI":"10.1074\/jbc.M109.098004","article-title":"miR-9 and NFATc3 regulate myocardin in cardiac hypertrophy","volume":"285","author":"Wang","year":"2010","journal-title":"J Biol Chem"},{"issue":"5","key":"2019041123325105900_B83","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.devcel.2009.10.013","article-title":"A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance","volume":"17","author":"van Rooij","year":"2009","journal-title":"Dev Cell"},{"issue":"5","key":"2019041123325105900_B84","doi-asserted-by":"crossref","first-page":"e38197","DOI":"10.1371\/journal.pone.0038197","article-title":"Aldosterone inhibits the fetal program and increases hypertrophy in the heart of hypertensive mice","volume":"7","author":"Azibani","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"2019041123325105900_B85","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/FJC.0000000000000227","article-title":"Spironolactone regulates HCN protein expression through micro-RNA-1 in rats with myocardial infarction","volume":"65","author":"Yu","year":"2015","journal-title":"J Cardiovasc Pharmacol"},{"issue":"3","key":"2019041123325105900_B86","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000268088","article-title":"MicroRNAs miR-1, miR-133a, miR-133b and miR-208 are dysregulated in human myocardial infarction","volume":"115","author":"Bostjancic","year":"2010","journal-title":"Cardiology"},{"issue":"5","key":"2019041123325105900_B87","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nm1582","article-title":"MicroRNA-133 controls cardiac hypertrophy","volume":"13","author":"Car\u00e8","year":"2007","journal-title":"Nat Med"},{"issue":"4","key":"2019041123325105900_B88","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nm1569","article-title":"The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2","volume":"13","author":"Yang","year":"2007","journal-title":"Nat Med"},{"issue":"6","key":"2019041123325105900_B89","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/eurjhf\/hft018","article-title":"Plasma microRNAs serve as biomarkers of therapeutic efficacy and disease progression in hypertension-induced heart failure","volume":"15","author":"Dickinson","year":"2013","journal-title":"Eur J Heart Fail"},{"issue":"48","key":"2019041123325105900_B90","doi-asserted-by":"crossref","first-page":"18255","DOI":"10.1073\/pnas.0608791103","article-title":"A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure","volume":"103","author":"van Rooij","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"2019041123325105900_B91","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1161\/01.RES.0000257913.42552.23","article-title":"MicroRNAs play an essential role in the development of cardiac hypertrophy","volume":"100","author":"Sayed","year":"2007","journal-title":"Circ Res"},{"issue":"1","key":"2019041123325105900_B92","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/cvr\/cvp015","article-title":"MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue","volume":"82","author":"Roy","year":"2009","journal-title":"Cardiovasc Res"},{"issue":"1","key":"2019041123325105900_B93","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000338149","article-title":"Expression of microRNA-1 and microRNA-21 in different protocols of ischemic conditioning in an isolated rat heart model","volume":"122","author":"Duan","year":"2012","journal-title":"Cardiology"},{"issue":"35","key":"2019041123325105900_B94","doi-asserted-by":"crossref","first-page":"13027","DOI":"10.1073\/pnas.0805038105","article-title":"Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis","volume":"105","author":"van Rooij","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"19","key":"2019041123325105900_B95","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1152\/physiolgenomics.00074.2011","article-title":"Temporal expression of miRNAs and mRNAs in a mouse model of myocardial infarction","volume":"43","author":"Port","year":"2011","journal-title":"Physiol Genomics"},{"issue":"6","key":"2019041123325105900_B96","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1161\/CIRCRESAHA.111.262717","article-title":"Lost in transgenesis: a user\u2019s guide for genetically manipulating the mouse in cardiac research","volume":"111","author":"Davis","year":"2012","journal-title":"Circ Res"},{"issue":"4","key":"2019041123325105900_B97","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1164\/rccm.201106-1093OC","article-title":"Inhibition of microRNA-17 improves lung and heart function in experimental pulmonary hypertension","volume":"185","author":"Pullamsetti","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"2019041123325105900_B98","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1161\/HYPERTENSIONAHA.113.03037","article-title":"Endothelial apoptosis in pulmonary hypertension is controlled by a microRNA\/programmed cell death 4\/caspase-3 axis","volume":"64","author":"White","year":"2014","journal-title":"Hypertension"},{"issue":"2","key":"2019041123325105900_B99","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1161\/HYPERTENSIONAHA.111.185520","article-title":"Oxidative stress causes mineralocorticoid receptor activation in rat cardiomyocytes: role of small GTPase Rac1","volume":"59","author":"Nagase","year":"2012","journal-title":"Hypertension"},{"issue":"1","key":"2019041123325105900_B100","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1161\/HYPERTENSIONAHA.115.06054","article-title":"Rac1-mediated activation of mineralocorticoid receptor in pressure overload-induced cardiac injury","volume":"67","author":"Ayuzawa","year":"2016","journal-title":"Hypertension"},{"issue":"10","key":"2019041123325105900_B101","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1074\/jbc.M113.519256","article-title":"The mineralocorticoid receptor promotes fibrotic remodeling in atrial fibrillation","volume":"289","author":"Lavall","year":"2014","journal-title":"J Biol Chem"},{"key":"2019041123325105900_B102","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.yjmcc.2015.05.019","article-title":"Inhibition of aldosterone synthase (CYP11B2) by torasemide prevents atrial fibrosis and atrial fibrillation in mice","volume":"85","author":"Adam","year":"2015","journal-title":"J Mol Cell Cardiol"},{"issue":"11","key":"2019041123325105900_B103","doi-asserted-by":"crossref","first-page":"4796","DOI":"10.1210\/en.2004-0295","article-title":"Origin of aldosterone in the rat heart","volume":"145","author":"Gomez-Sanchez","year":"2004","journal-title":"Endocrinology"},{"issue":"12","key":"2019041123325105900_B104","doi-asserted-by":"crossref","first-page":"5287","DOI":"10.1210\/en.2005-0370","article-title":"The aldosterone synthase (CYP11B2) and 11beta-hydroxylase (CYP11B1) genes are not expressed in the rat heart","volume":"146","author":"Ye","year":"2005","journal-title":"Endocrinology"},{"key":"2019041123325105900_B105","article-title":"MRX34, a liposomal miR-34 mimic, in patients with advanced solid tumors: final dose-escalation results from a first-in-human phase I trial of microRNA therapy","author":"Hong","year":"2016","journal-title":"J Clin Oncol"},{"key":"2019041123325105900_B106","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-pharmtox-011613-135957","article-title":"microRNA therapeutics in cardiovascular disease models","volume":"54","author":"Dangwal","year":"2014","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"7","key":"2019041123325105900_B107","doi-asserted-by":"crossref","first-page":"851","DOI":"10.15252\/emmm.201100899","article-title":"Development of microRNA therapeutics is coming of age","volume":"6","author":"van Rooij","year":"2014","journal-title":"EMBO Mol Med"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/158\/6\/1859\/17643214\/en.2016-1707.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T18:33:29Z","timestamp":1555094009000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/158\/6\/1859\/3075149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,20]]},"references-count":107,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,3,20]]},"published-print":{"date-parts":[[2017,6,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2016-1707","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,6,1]]},"published":{"date-parts":[[2017,3,20]]}}}